IL-4/IL-13 upregulates Sonic hedgehog expression to induce allergic airway epithelial remodeling

Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L888-L899. doi: 10.1152/ajplung.00186.2019. Epub 2020 Mar 4.

Abstract

We have previously demonstrated that upregulation of Sonic hedgehog (SHH) expression in allergic airway epithelia essentially contributes to the goblet cell metaplasia and mucous hypersecretion. However, the mechanism underlying the upregulation of SHH expression remains completely unknown. In cultured human airway epithelial cells, IL-4/IL-13 but not IL-5 robustly induces the mRNA and protein expression of SHH and in turn activates SHH signaling by promoting the JAK/STAT6-controlling transcription of SHH gene. Moreover, intratracheal instillation of IL-4 and/or IL-13 robustly activates STAT6 and concomitantly upregulates SHH expression in mouse airway epithelia, whereas, in Club cell 10-kDa protein (CC10)-positive airway epithelial cells of children with asthma, activated STAT6 closely correlates with the increased expression of SHH and high activity of SHH signaling. Finally, intratracheal inhibition of STAT6 by AS-1517499 significantly diminished the allergen-induced upregulation of SHH expression, goblet cell phenotypes, and airway hyperresponsiveness, in an ovalbumin- or house dust mite-induced mouse model with allergic airway inflammation,. Together, upregulation of SHH expression by IL-4/IL-13-induced JAK/STAT6 signaling contributes to allergic airway epithelial remodeling, and this study thus provides insight into how morphogen signaling is coordinated with Th2 cytokine pathways to regulate tissue remodeling in chronic airway diseases.

Keywords: IL-13; IL-4; Sonic hedgehog; airway remodeling; allergy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Asthmatic Agents / pharmacology
  • Asthma / chemically induced
  • Asthma / drug therapy
  • Asthma / genetics*
  • Asthma / pathology
  • Cell Line
  • Child
  • Female
  • Gene Expression Regulation
  • Goblet Cells / drug effects
  • Goblet Cells / immunology
  • Goblet Cells / pathology
  • Hedgehog Proteins / genetics*
  • Hedgehog Proteins / immunology
  • Humans
  • Interleukin-13 / genetics*
  • Interleukin-13 / immunology
  • Interleukin-13 / pharmacology
  • Interleukin-4 / genetics*
  • Interleukin-4 / immunology
  • Interleukin-4 / pharmacology
  • Interleukin-5 / genetics
  • Interleukin-5 / immunology
  • Janus Kinases / genetics
  • Janus Kinases / immunology
  • Mice
  • Mice, Inbred BALB C
  • Ovalbumin / administration & dosage
  • Primary Cell Culture
  • Pyrimidines / pharmacology
  • Pyroglyphidae / chemistry
  • Pyroglyphidae / immunology
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / immunology*
  • Respiratory Mucosa / pathology
  • STAT6 Transcription Factor / antagonists & inhibitors
  • STAT6 Transcription Factor / genetics
  • STAT6 Transcription Factor / immunology
  • Signal Transduction
  • Transcription, Genetic
  • Uteroglobin / genetics
  • Uteroglobin / immunology

Substances

  • 4-(benzylamino)-2-((2-(3-chloro-4-hydroxyphenyl)ethyl)amino)pyrimidine-5-carboxamide
  • Anti-Asthmatic Agents
  • Hedgehog Proteins
  • IL13 protein, human
  • IL4 protein, human
  • IL5 protein, human
  • Interleukin-13
  • Interleukin-5
  • Pyrimidines
  • SCGB1A1 protein, human
  • SHH protein, human
  • STAT6 Transcription Factor
  • STAT6 protein, human
  • Interleukin-4
  • Ovalbumin
  • Uteroglobin
  • Janus Kinases